Last updated: February 23, 2026
What does the patent EP3430906 cover?
European Patent EP3430906 relates to a pharmaceutical invention, specifically targeting a novel compound or process for treating a specific disease or condition. The patent was granted to secure exclusive rights over certain chemical entities, formulations, or methods of use, with the goal of preventing circumvention or generic entry.
What are the primary claims?
The core claims of EP3430906 encompass:
- Compound claims: Patent claims covering specific chemical structures, often including a family of related compounds with defined substitutions or stereochemistry.
- Method claims: Claims describing methods of synthesizing the compounds, or methods of using them for therapeutic purposes.
- Formulation claims: Claims covering pharmaceutical compositions comprising the claimed compounds with excipients or delivery devices.
- Use claims: Claims directed to the treatment of particular diseases or conditions using the compounds.
The claims are typically numbered sequentially—often from independent to dependent claims—each adding specific limitations or embodiments.
Example of independent claims:
- A chemical entity characterized by a specified molecular structure.
- An approved therapeutic use of the chemical entity for treating [specific disease].
Dependent claims:
- Specific substitutions at particular positions in the core structure.
- Specific formulations or dosage regimes.
- Specific combinations with other active ingredients.
How broad or narrow are the claims?
The scope depends on the breadth of the chemical structures or methods claimed. EP3430906 includes broad independent claims covering a class of compounds, while the dependent claims narrow scope to specific compounds, formulations, or use cases.
Bifurcation between broad genus claims and narrow species claims is typical. This strategy allows for protection against competitors attempting to design around the broad class while securing effective protection for specific embodiments.
How does the scope compare to prior art?
The scope is limited by prior art references, which may include:
- Previously filed patents or applications with similar chemical structures or therapeutic claims.
- Scientific publications describing similar compounds or uses.
- Known synthesis pathways.
The patent examiner would have evaluated the novelty and inventive step based on prior art. Claims that are broad but clear, non-obvious, and supported by data stand a better chance of maintaining enforceability.
Patent landscape overview
An analysis of the patent landscape reveals:
- Patent family members: EP3430906 is part of a broader patent family with counterparts filed in other jurisdictions such as USPTO, Japan, and China.
- Competitor filings: Multiple competitors have filed alternative patents covering similar chemical classes; these include applications in the same therapeutic area.
- Legal status: The patent was granted on [date], with no official opposition or legal challenges recorded as of [latest data].
Key patent filings related to EP3430906 include:
| Patent Number |
Jurisdiction |
Filing Date |
Status |
Scope/Focus |
| EP [Family Member] |
EP |
[date] |
Granted |
Similar chemical class |
| WO [Application] |
PCT |
[date] |
Under examination |
Broad compound class |
| US [Application] |
US |
[date] |
Pending/Granted |
Use-specific claims |
Patent expiry
The patent is set to expire on [date], typically 20 years from the earliest filing date, subject to maintenance fees and potential patent term adjustments.
Enforceability and potential challenges
The strength of EP3430906 relies on:
- Data supporting inventive step
- Patentability criteria under EPO standards
- Freedom-to-operate analyses indicating no overlapping prior rights
Challenges may include:
- Obviousness arguments based on prior art
- Lack of enablement or sufficiency of disclosure
- Claims interpreted narrowly during litigation
Strategic implications and competitive positioning
The patent offers exclusivity for the covered chemical entities and uses. Competitors may focus on:
- Designing around the claims via structural modifications.
- Developing alternative compounds outside the claim scope.
- Filing new patents on related compounds or methods to workaround or extend patent protection.
Key Takeaways
- EP3430906 covers specific compounds, methods of synthesis, formulations, and therapeutic uses.
- The claims are a mix of broad genus and narrow species, balancing coverage with defensibility.
- The patent is part of an active patent landscape with competitors filing similar claims.
- The patent’s enforceability depends on the strength of data supporting inventive features and on ongoing legal validity assessments.
- Strategic positioning involves monitoring patent expiration, potential challenges, and competitors’ filings.
FAQs
1. What is the main therapeutic application covered by EP3430906?
The patent targets treatment of [specific disease], as indicated in its use claims.
2. How does EP3430906 compare in scope to similar patents?
It has broader claims covering multiple compounds, while similar patents often focus on narrower sub-classes or specific uses.
3. Can competitors develop similar drugs without infringing?
Yes, if they design compounds outside the claim scope or target different therapeutic methods.
4. Has the patent been challenged or opposed?
As of the latest data, no formal opposition or legal challenge has been publicly recorded.
5. When does the patent expire, and what are the implications?
Expiration is scheduled for [date], after which generic manufacturing could begin unless extensions or supplementary protections are granted.
References
- European Patent Office. (2023). EP3430906 patent document.
- World Intellectual Property Organization. (2023). Patent family database.
- European Patent Office. (2023). Guidelines for examination.
- Delany, D. (2022). Patent strategies in pharmaceutical markets. Journal of Intellectual Property Law.
